• Epicept Corp., of Tarrytown, N.Y., and Immune Pharmaceuticals Ltd., of Herzliya-Pituach, Israel, said the 1-for-40 reverse stock split of Epicept's common stock and the company's name change to Immune Pharmaceuticals Inc., in conjunction with the merger of the two firms, is expected to be completed at the end of the week.